Epic Bio: Epicrispr Biotechnologies is a pre-clinical stage gene therapy company building the world’s most expansive therapeutic pipeline based on the emerging science of epigenetic engineering. Led by CRISPR pioneer Lei Stanley Qi, PhD, Epic has developed the Gene Expression Modulation System (GEMS) platform, designed to dial gene expression up or down without permanently altering the DNA, and uses Cas12f to deliver genetic therapies that act on the epigenome. The Company's unique epigenetic approach presents enormous therapeutic potential for countless complex diseases.